Phase 2 study of lenvatinib in patients with RET fusion-positive adenocarcinoma of the lung
Velcheti, V, Hida, T, Reckamp, K.L, Yang, J.C, Nokihara, H, Sachdev, P, Feit, K, Kubota, T, Nakada, T, Dutcus, C.E, Ren, M, Tamura, T
Published in European journal of cancer (1990) (01.02.2017)
Published in European journal of cancer (1990) (01.02.2017)
Get full text
Journal Article
Carboplatin/ nab -Paclitaxel and Pembrolizumab for Patients with Advanced Non–Small Cell Lung Cancer (NSCLC): Phase 1 Results
Gentzler, R.D, Mohindra, N.A, Hanna, N, Chae, Y.K, Jalal, S.I, Hall, R, Villaflor, V.M, Reckamp, K.L, Koczywas, M, Sullivan, D, Wood, L, Patel, J.D
Published in International journal of radiation oncology, biology, physics (01.05.2017)
Published in International journal of radiation oncology, biology, physics (01.05.2017)
Get full text
Journal Article
Final Results of a Phase 3 Trial of Celecoxib (C) in Addition to Standard Chemotherapy for Advanced Non–Small Cell Lung Cancer With COX- 2 Overexpression: CALGB 30801 (Alliance)
Edelman, M.J, Wang, X, Hodgson, L, Cheney, R.T, Baggstrom, M.Q, Sachdev, T, Gajra, A, Bertino, E.M, Reckamp, K.L, Molina, J, Schiller, J, Mitchell-Edwards, K, Friedman, P, Ritter, J, Milne, G, Stinchcombe, T.E, Hahn, O, Vokes, E.E
Published in International journal of radiation oncology, biology, physics (01.05.2017)
Published in International journal of radiation oncology, biology, physics (01.05.2017)
Get full text
Journal Article
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
Passaro, A, Wang, J, Wang, Y, Lee, S-H, Melosky, B, Shih, J-Y, Wang, J, Azuma, K, Juan-Vidal, O, Cobo, M, Felip, E, Girard, N, Cortot, A B, Califano, R, Cappuzzo, F, Owen, S, Popat, S, Tan, J-L, Salinas, J, Tomasini, P, Gentzler, R D, William, Jr, W N, Reckamp, K L, Takahashi, T, Ganguly, S, Kowalski, D M, Bearz, A, MacKean, M, Barala, P, Bourla, A B, Girvin, A, Greger, J, Millington, D, Withelder, M, Xie, J, Sun, T, Shah, S, Diorio, B, Knoblauch, R E, Bauml, J M, Campelo, R G, Cho, B C
Published in Annals of oncology (01.01.2024)
Published in Annals of oncology (01.01.2024)
Get full text
Journal Article
1309P A genomic scar based signature (HRDsig) and biallelic BRCA alterations identify a homologous recombination deficiency (HRD) phenotype of non-small cell lung cancer (NSCLC) potentially actionable to the PARP inhibitor rucaparib: Post-hoc analysis of lung-MAP substudy S1900A
Riess, J.W., Miao, J., Wheatley-Price, P., Reckamp, K.L., Kozono, D., Redman, M.W., Edelman, M.J., Faller, B., Villaruz, L., Corum, L., Gowda, A., Srkalovic, G., Osarogiagbon, R., Baumgart, M., Gandara, D.R., Sokol, E.S., Borghaei, H., Gray, J.E., Herbst, R.S., Kelly, K.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
Role of Adjuvant Therapy in Clinically N2 Non-Small Cell Lung Cancer Patients Undergoing Neoadjuvant Chemotherapy and Surgery
Shinde, A., Li, R., Glaser, S.M., Massarelli, E., Koczywas, M., Reckamp, K.L., Salgia, R., Amini, A.
Published in International journal of radiation oncology, biology, physics (01.05.2019)
Published in International journal of radiation oncology, biology, physics (01.05.2019)
Get full text
Journal Article
LBA54 Amivantamab plus chemotherapy vs chemotherapy in EGFR-mutated, advanced non-small cell lung cancer after disease progression on osimertinib: Second interim overall survival from MARIPOSA-2
Popat, S., Reckamp, K.L., Califano, R., Lee, S-H., Melosky, B., Wang, J., Wang, Y., García Campelo, M.R., Felip, E., Girard, N., Gentzler, R.D., Nassib William Junior, W., Takahashi, T., Nagasaka, M., Bauml, J.M., Shah, S., Diorio, B., Chu, P-L., Cho, B.C., Passaro, A.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
LBA15 Amivantamab plus chemotherapy (with or without lazertinib) vs chemotherapy in EGFR-mutated advanced NSCLC after progression on osimertinib: MARIPOSA-2, a phase III, global, randomized, controlled trial
Passaro, A., Cho, B.C., Wang, Y., Melosky, B., Califano, R., Lee, S-H., Girard, N., Reckamp, K.L., Takahashi, T., Felip, E., Gentzler, R.D., Popat, S., Nassib William Junior, W., Sun, T., Shah, S., Diorio, B., Knoblauch, R.E., Bauml, J.M., García-Campelo, M.R., Wang, J.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer
Carter, C.A., Rajan, A., Keen, C., Szabo, E., Khozin, S., Thomas, A., Brzezniak, C., Guha, U., Doyle, L.A., Steinberg, S.M., Xi, L., Raffeld, M., Tomita, Y., Lee, M.J., Lee, S., Trepel, J.B., Reckamp, K.L., Koehler, S., Gitlitz, B., Salgia, R., Gandara, D., Vokes, E., Giaccone, G.
Published in Annals of oncology (01.04.2016)
Published in Annals of oncology (01.04.2016)
Get full text
Journal Article
1611P Health-related quality of life, vaccine uptake and immune response among cancer patients undergoing treatment during the COVID-19 pandemic
Figueiredo, J.C., Merin, N., Ihenacho, U., Hamid, O., Hendifar, A.E., Vescio, R., Paquette, R., Natale, R.B., Darrah, J., Basho, R., McArthur, H., Nguyen, N., Punwani, N., Herrera, E., Cheng, S., Salvy, S-J., Datta, G., Figlin, R., Merchant, A., Reckamp, K.L.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
1247P Management of infusion-related reactions (IRRs) in patients receiving amivantamab
Park, K., Sabari, J.K., Haura, E.B., Shu, C.A., Spira, A., Salgia, R., Reckamp, K.L., Sanborn, R.E., Govindan, R., Bauml, J.M., Curtin, J.C., Xie, J., Roshak, A., Lorenzini, P., Millington, D., Thayu, M., Knoblauch, R.E., Cho, B.C.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
EP08.02-019 Phase 1/2 Study of BLU-701, a Highly Selective EGFR Inhibitor, in Patients With EGFR-Mutant Non-Small Cell Lung Cancer
Spira, A., Spigel, D.R., Camidge, R., de Langen, A.J., Kim, T.M., Goto, K., Elamin, Y., Shum, E., Reckamp, K.L., Rotow, J., Goldberg, S., Gadgeel, S., Leal, T.A., Albayya, F., Fitzpatrick, S., Louie-Gao, M., Parepally, J., Zalutskaya, A., Yu, H.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article
EP08.02-045 Phase 1/2 Study of BLU-945 in Patients With Common Activating EGFR-Mutant Non-Small Cell Lung Cancer
Shum, E., Elamin, Y., Piotrowska, Z., Spigel, D.R., Reckamp, K.L., Rotow, J., Tan, D.S.W., Lim, S.M., Kim, T.M., Lin, C.-C., Kato, T., Parepally, J., Albayya, F., Louie-Gao, M., Weining, T., Zalutskaya, A., Goto, K.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article
KRAS in non-small cell lung cancer
Amanam, I., Gupta, R., Mambetsariev, I., Koczywas, M., Cristea, M., Massarelli, E., Reckamp, K.L., Salgia, R.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Prognostic factors in crizotinib (CRZ)-resistant anaplastic lymphoma kinase (ALK+) non-small cell lung cancer (NSCLC) patients (Pts)
Reckamp, K.L., Lee, J., Huang, J., Proskorovsky, I., Reichmann, W., Krotneva, M., Kerstein, D., Huang, H.
Published in Annals of oncology (01.04.2017)
Published in Annals of oncology (01.04.2017)
Get full text
Journal Article
PCN169 - A FLEXIBLE OPEN-SOURCE COST-EFFECTIVENESS MODEL FOR METASTATIC EGFR+ NON-SMALL CELL LUNG CANCER
Jansen, J.P., Incerti, D., Shafrin, J., Frederickson, A.M., Lakdawalla, D.N., Reckamp, K.L.
Published in Value in health (01.10.2018)
Published in Value in health (01.10.2018)
Get full text
Journal Article
Phase 2 study of lenvatinib (LN) in patients (Pts) with RET fusion-positive adenocarcinoma of the lung
Velcheti, V., Hida, T., Reckamp, K.L., Yang, J.C., Nokihara, H., Sachdev, P., Feit, K., Kubota, T., Nakada, T., Dutcus, C.E., Ren, M., Tamura, T.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment
Figueiredo, J.C., Ihenacho, U., Merin, N.M., Hamid, O., Darrah, J., Gong, J., Paquette, R., Mita, A.C., Vescio, R., Mehmi, I., Basho, R., Salvy, S.J., Shirazipour, C.H., Caceres, N., Finster, L.J., Coleman, B., Arnow, H.U., Florindez, L., Sobhani, K., Prostko, J.C., Frias, E.C., Stewart, J.L., Merchant, A., Reckamp, K.L.
Published in Annals of oncology (01.01.2022)
Published in Annals of oncology (01.01.2022)
Get full text
Journal Article
Factors Predicting for Early Mortality in Non-Small Cell Lung Cancer
Amini, A., Glaser, S.M., Akhavan, D., Li, R., Nelson, R., Stokes, W.A., Koczywas, M., Reckamp, K.L., Salgia, R., Gaspar, L.E., Kavanagh, B.D., Rusthoven, C.G., Liu, A.K.
Published in International journal of radiation oncology, biology, physics (01.11.2018)
Published in International journal of radiation oncology, biology, physics (01.11.2018)
Get full text
Journal Article
PD2.04 Long Term Efficacy and Safety of Ensartinib in Pre-Treated Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Patients (eXalt2)
Leal, T., Wakelee, H., Reckamp, K.L., Chiappori, A., Oxnard, G.R., Waqar, S.N., Patel, S.P., Blumenschein, G.R., Neal, J.W., Harrow, K., Holzhausen, A., Selvaggi, G., Zhou, J., Horn, L.
Published in Journal of thoracic oncology (01.11.2019)
Published in Journal of thoracic oncology (01.11.2019)
Get full text
Journal Article